Biopharma has received clearance from the U.S. Food and Drug Administration (FDA) for its Investigational New Drug (IND) application of CD-001, entering a Phase I first-in-human trial. CD-001, the ...
2024年9月4日,上海交通大学生物医学工程学院夏伟梁团队和上海交通大学医学院附属胸科医院陆舜团队合作在 Science Translational Medicine 上发表了题为PTPRT loss enhances anti-PD-1 therapy efficacy by regulation of STING pathway in non-small cell lung cancer 的 ...